Login Register Cart 0
Generic placeholder image

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

The Association between Vitamin D Deficiency and Fibrocystic Breast Disorder

Author(s): Sheida Shabanian, Aliyeh Rozbeh, Belgheis Mohammadi, Ali Ahmadi and Mohammad-Hassan Arjmand*

Volume 24, Issue 7, 2024

Published on: 16 August, 2023

Page: [899 - 905] Pages: 7

DOI: 10.2174/1566524023666230623155659

Price: $65

Abstract

Background: The role of deficiency of vitamin D in a wide range of human cancer, including breast cancer, has been proven, but its role in benign breast diseases remains unknown. This study aimed to determine the prevalence of vitamin D deficiency in patients with fibrocystic breast (FB) disease.

Methods: First, the hospital prevalence of fibrocystic breast was determined by a crosssectional study. Then, patients were divided into two groups by a case-control study; women with confirmed fibrocystic breasts based on breast pain, physical examination, and ultrasonography were included as a case group (N=48), and age-matched women without fibrocystic breasts were also included as a control group (N=48). After recording the demographic and gynecological characteristics and exposure to the sun, gynecological records, and family history of fibrocystic breast, the blood sample was taken to determine vitamin D. Data were analyzed by Stata software.

Results: The result indicated that the studied groups had significant differences in regards to weight, breast pain, the severity of breast pain, breast heaviness, family history of fibrocystic breast, history of breast disease, caffeine consumption, and exposure to sunlight (p <0.05), but did not show significant differences based on age, occupation, education, gynecological history, diabetes mellitus, hypertension, obesity and hypothyroidism, vegetable, fast food, and dairy products consumption. The frequency of vitamin D deficiency in the case group was 45.8%, and in the control group, it was 20.8%, and there was a statistically significant difference (p <0.05).

Conclusion: Vitamin D deficiency is more common in women with fibrocystic breast disease and may play a role in the development of the disease.

« Previous Next »
[1]
Taklif M, Hassan Pour A. The prevalence of fibrocystic changes in mammoplasty specimen referred to hazrat fatemeh hospital from 1994 to 2002. Majallah-i Ulum-i Pizishki-i Razi 2004; 10(38): 829-33.
[2]
Norwood SL. Fibrocystic breast disease. An update and review. J Obstet Gynecol Neonatal Nurs 1990; 19(2): 116-21.
[http://dx.doi.org/10.1111/j.1552-6909.1990.tb01629.x] [PMID: 2181087]
[3]
Stachs A, Stubert J, Reimer T, Hartmann S. Benign breast disease in women. Dtsch Arztebl Int 2019; 116(33-34): 565-74.
[PMID: 31554551]
[4]
Arulkumaran S. Essentials of gynecology. LWW Wolters Kluwer 2005; p. 698.
[5]
Emans SJH, Laufer MR, Goldstein DP. Emans, Laufer, Goldstein’s Pediatric and Adolescent Gynecology. Pennsylvania, United States: Wolters Kluwer Health 2005.
[6]
Alikhassi A, Comparing BI-RADS. With the 2003 edition: has it worked better? Arch Breast Cancer 2013; 2019: 51-4.
[7]
Malherbe K, Khan M, Fatima S. Fibrocystic breast disease. StatPearls 2019.
[8]
Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357(3): 266-81.
[http://dx.doi.org/10.1056/NEJMra070553] [PMID: 17634462]
[9]
Cashman KD, Dowling KG, Škrabáková Z, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr 2016; 103(4): 1033-44.
[http://dx.doi.org/10.3945/ajcn.115.120873] [PMID: 26864360]
[10]
Heshmat R, et al. Vitamin D deficiency in Iran: A multi-center study among different urban areas. Iran J Public Health 2008; 37(1): 72-8.
[11]
Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem Biophys 2012; 523(1): 123-33.
[http://dx.doi.org/10.1016/j.abb.2012.04.001] [PMID: 22503810]
[12]
Wu Y, Sarkissyan M, Clayton S, Chlebowski R, Vadgama JV. Association of vitamin D3 level with breast cancer risk and prognosis in African-American and Hispanic women. Cancers 2017; 9(12): 144.
[http://dx.doi.org/10.3390/cancers9100144] [PMID: 29064397]
[13]
Spina CS, Tangpricha V, Uskokovic M, Adorinic L, Maehr H, Holick MF. Vitamin D and cancer. Anticancer Res 2006; 26(4A): 2515-24.
[PMID: 16886659]
[14]
Alipour S, Hadji M, Hosseini L, et al. Levels of serum 25-hydroxy-vitamin d in benign and malignant breast masses. Asian Pac J Cancer Prev 2014; 15(1): 129-32.
[http://dx.doi.org/10.7314/APJCP.2014.15.1.129] [PMID: 24528013]
[15]
O’Brien S, Kowdley GC. Benign breast diseases and body mass index: is there a correlation? Am Surg 2014; 80(5): 461-5.
[http://dx.doi.org/10.1177/000313481408000516] [PMID: 24887724]
[16]
Wrensch MR, Petrakis NL, King EB, et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol 1992; 135(2): 130-41.
[http://dx.doi.org/10.1093/oxfordjournals.aje.a116266] [PMID: 1536131]
[17]
Chen YY, Fang WH, Wang CC, et al. Examining the associations among fibrocystic breast change, total lean mass, and percent body fat. Sci Rep 2018; 8(1): 9180.
[http://dx.doi.org/10.1038/s41598-018-27546-3] [PMID: 29907750]
[18]
Bhettani MK, Rehman M, Altaf HN, et al. Correlation between body mass index and fibroadenoma. Cureus 2019; 11(7): e5219.
[http://dx.doi.org/10.7759/cureus.5219] [PMID: 31565622]
[19]
Maskarinec G, Jacobs S, Park SY, et al. Type II Diabetes, Obesity, and Breast Cancer Risk: The Multiethnic Cohort. Cancer Epidemiol Biomarkers Prev 2017; 26(6): 854-61.
[http://dx.doi.org/10.1158/1055-9965.EPI-16-0789] [PMID: 28087607]
[20]
Kang C, LeRoith D, Gallagher EJ. Diabetes, obesity, and breast cancer. Endocrinology 2018; 159(11): 3801-12.
[http://dx.doi.org/10.1210/en.2018-00574] [PMID: 30215698]
[21]
Talaei A, Moradi A, Rafiei F. The evaluation of the effect of metformin on breast fibrocystic disease. Breast Dis 2017; 37(2): 49-53.
[http://dx.doi.org/10.3233/BD-160256] [PMID: 28598826]
[22]
Vakil DV, Elinson L, Morgan RW. Cystic disease, family history of breast cancer, and use of oral contraceptives. Cancer Detect Prev 1981; 4(1-4): 511-5.
[PMID: 7349817]
[23]
Coriaty Nelson Z, Ray RM, Gao DL, Thomas DB. Risk factors for fibroadenoma in a cohort of female textile workers in Shanghai, China. Am J Epidemiol 2002; 156(7): 599-605.
[http://dx.doi.org/10.1093/aje/kwf094] [PMID: 12244028]
[24]
Wu C, Ray RM, Lin MG, et al. A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000. Am J Epidemiol 2004; 160(10): 945-60.
[http://dx.doi.org/10.1093/aje/kwh318] [PMID: 15522851]
[25]
Yousif ZH, Yacoub SE. Patterns of breast diseases among women attending breast diseases diagnosing center in erbil city/Iraq. Glob J Health Sci 2018; 10(4): 114-4.
[http://dx.doi.org/10.5539/gjhs.v10n4p114]
[26]
Zangana A, Garota S. Risk factors of breast cancer in a sample of Kurdish women of Kurdistan region - Iraq: A comparative study between pre-menopausal and post-menopausal women. Zanco J Med Sci 2012; 16(3): 262-7.
[http://dx.doi.org/10.15218/zjms.2012.0044]
[27]
Goehring C, Morabia A. Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev 1997; 19(2): 310-27.
[http://dx.doi.org/10.1093/oxfordjournals.epirev.a017960] [PMID: 9494790]
[28]
Hunter DJ. Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med 1996; 334(6): 356-61.
[29]
Rohan TE, Negassa A, Caan B, et al. Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial. Cancer Prev Res (Phila) 2008; 1(4): 275-84.
[http://dx.doi.org/10.1158/1940-6207.CAPR-08-0003] [PMID: 19138971]
[30]
Boyle CA, Berkowitz GS, LiVolsi VA, et al. Caffeine consumption and fibrocystic breast disease: a case-control epidemiologic study. J Natl Cancer Inst 1984; 72(5): 1015-9.
[PMID: 6585579]
[31]
Su X, Colditz GA, Collins LC, et al. Adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease. Breast Cancer Res Treat 2012; 134(2): 783-91.
[http://dx.doi.org/10.1007/s10549-012-2091-8] [PMID: 22622809]
[32]
Baer HJ, Schnitt SJ, Connolly JL, et al. Adolescent diet and incidence of proliferative benign breast disease. Cancer Epidemiol Biomarkers Prev 2003; 12(11 Pt 1): 1159-67.
[PMID: 14652275]
[33]
Hislop TG, Band PR, Deschamps M, et al. Diet and histologic types of benign breast disease defined by subsequent risk of breast cancer. Am J Epidemiol 1990; 131(2): 263-70.
[http://dx.doi.org/10.1093/oxfordjournals.aje.a115496] [PMID: 2296979]
[34]
Boeke CE, Tamimi RM, Berkey CS, et al. Adolescent dietary vitamin D and sun exposure in relation to benign breast disease. Cancer Causes Control 2015; 26(8): 1181-7.
[http://dx.doi.org/10.1007/s10552-015-0612-6] [PMID: 26084210]
[35]
Lopes N, Paredes J, Costa JL, Ylstra B, Schmitt F. Vitamin D and the mammary gland: a review on its role in normal development and breast cancer. Breast Cancer Res 2012; 14(3): 211.
[http://dx.doi.org/10.1186/bcr3178] [PMID: 22676419]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy